Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Viral | 19 | 2023 | 262 | 2.750 |
Why?
|
| Viral Vaccines | 9 | 2022 | 29 | 2.580 |
Why?
|
| West Nile Fever | 7 | 2021 | 56 | 2.350 |
Why?
|
| Rift Valley Fever | 3 | 2022 | 7 | 2.230 |
Why?
|
| Rift Valley fever virus | 4 | 2022 | 8 | 1.820 |
Why?
|
| West Nile virus | 6 | 2021 | 65 | 1.760 |
Why?
|
| Dengue Virus | 8 | 2021 | 85 | 1.750 |
Why?
|
| Dengue | 8 | 2020 | 94 | 1.680 |
Why?
|
| Culicidae | 7 | 2019 | 24 | 1.290 |
Why?
|
| Deer | 3 | 2023 | 11 | 1.180 |
Why?
|
| Antibodies, Neutralizing | 9 | 2023 | 109 | 1.120 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 3 | 2022 | 9 | 1.020 |
Why?
|
| Seroepidemiologic Studies | 7 | 2021 | 68 | 0.960 |
Why?
|
| Leptospirosis | 3 | 2022 | 25 | 0.950 |
Why?
|
| Malaria | 3 | 2022 | 78 | 0.930 |
Why?
|
| Serologic Tests | 2 | 2020 | 43 | 0.910 |
Why?
|
| Arboviruses | 1 | 2022 | 5 | 0.870 |
Why?
|
| Aotidae | 2 | 2019 | 4 | 0.700 |
Why?
|
| Goat Diseases | 1 | 2019 | 3 | 0.680 |
Why?
|
| Sentinel Surveillance | 1 | 2019 | 21 | 0.680 |
Why?
|
| Peru | 15 | 2022 | 30 | 0.650 |
Why?
|
| Cattle | 1 | 2019 | 477 | 0.620 |
Why?
|
| Animals | 38 | 2023 | 15081 | 0.620 |
Why?
|
| Texas | 7 | 2023 | 324 | 0.610 |
Why?
|
| Vaccines, Attenuated | 3 | 2022 | 72 | 0.430 |
Why?
|
| Floods | 1 | 2011 | 6 | 0.410 |
Why?
|
| Insect Vectors | 5 | 2021 | 25 | 0.400 |
Why?
|
| Chagas Disease | 2 | 2022 | 98 | 0.370 |
Why?
|
| Trypanosoma cruzi | 2 | 2022 | 149 | 0.360 |
Why?
|
| Tanzania | 2 | 2019 | 7 | 0.340 |
Why?
|
| Mexico | 2 | 2020 | 240 | 0.330 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 237 | 0.320 |
Why?
|
| Protein Subunits | 1 | 2008 | 87 | 0.320 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 515 | 0.310 |
Why?
|
| Humans | 35 | 2022 | 37093 | 0.310 |
Why?
|
| Female | 22 | 2021 | 20969 | 0.300 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 1371 | 0.260 |
Why?
|
| Chikungunya virus | 2 | 2018 | 16 | 0.260 |
Why?
|
| Cricetinae | 7 | 2012 | 238 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 448 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 4 | 2022 | 661 | 0.240 |
Why?
|
| Severe Acute Respiratory Syndrome | 3 | 2009 | 5 | 0.240 |
Why?
|
| Swine Diseases | 1 | 2023 | 5 | 0.230 |
Why?
|
| Vero Cells | 7 | 2023 | 93 | 0.220 |
Why?
|
| Poxviridae | 1 | 2022 | 1 | 0.220 |
Why?
|
| Disease Vectors | 2 | 2012 | 10 | 0.220 |
Why?
|
| Virus Replication | 5 | 2019 | 278 | 0.220 |
Why?
|
| Anopheles | 2 | 2012 | 17 | 0.210 |
Why?
|
| Rivers | 1 | 2022 | 44 | 0.210 |
Why?
|
| Fever | 1 | 2022 | 57 | 0.210 |
Why?
|
| Flavivirus | 2 | 2019 | 15 | 0.210 |
Why?
|
| Male | 16 | 2021 | 20025 | 0.200 |
Why?
|
| Mice | 11 | 2022 | 5913 | 0.200 |
Why?
|
| Orthobunyavirus | 2 | 2011 | 3 | 0.200 |
Why?
|
| Triatoma | 1 | 2021 | 4 | 0.190 |
Why?
|
| Cluster Analysis | 2 | 2012 | 195 | 0.190 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2021 | 3 | 0.190 |
Why?
|
| Pregnant Women | 1 | 2020 | 48 | 0.180 |
Why?
|
| Reassortant Viruses | 2 | 2011 | 10 | 0.180 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 4 | 0.170 |
Why?
|
| Yellow fever virus | 2 | 2013 | 3 | 0.170 |
Why?
|
| Arbovirus Infections | 2 | 2019 | 5 | 0.170 |
Why?
|
| Goats | 1 | 2019 | 19 | 0.170 |
Why?
|
| Senegal | 5 | 2019 | 6 | 0.170 |
Why?
|
| Serial Passage | 2 | 2022 | 5 | 0.170 |
Why?
|
| Geography | 4 | 2012 | 96 | 0.160 |
Why?
|
| Biodiversity | 1 | 2019 | 83 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2009 | 31 | 0.160 |
Why?
|
| Virology | 1 | 2017 | 7 | 0.150 |
Why?
|
| RNA Viruses | 2 | 2019 | 22 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 186 | 0.150 |
Why?
|
| Yellow Fever | 2 | 2010 | 4 | 0.150 |
Why?
|
| Pregnancy | 3 | 2020 | 1549 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 307 | 0.150 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 21 | 0.140 |
Why?
|
| Mesocricetus | 4 | 2010 | 54 | 0.140 |
Why?
|
| Encephalitis Virus, Eastern Equine | 2 | 2007 | 2 | 0.140 |
Why?
|
| Encephalomyelitis, Equine | 2 | 2007 | 2 | 0.140 |
Why?
|
| Adult | 10 | 2018 | 11712 | 0.140 |
Why?
|
| Epitopes | 1 | 2016 | 148 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 54 | 0.140 |
Why?
|
| Aedes | 2 | 2008 | 34 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 159 | 0.140 |
Why?
|
| Climate | 1 | 2014 | 14 | 0.130 |
Why?
|
| Ecosystem | 2 | 2012 | 123 | 0.120 |
Why?
|
| Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hemorrhagic Fever, Crimean | 1 | 2013 | 1 | 0.120 |
Why?
|
| Viral Structural Proteins | 1 | 2013 | 16 | 0.110 |
Why?
|
| Nucleocapsid Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 24 | 0.110 |
Why?
|
| Insect Viruses | 1 | 2012 | 2 | 0.110 |
Why?
|
| Culex | 1 | 2012 | 3 | 0.110 |
Why?
|
| Phlebotomus | 1 | 2012 | 2 | 0.110 |
Why?
|
| Antigens, Viral | 1 | 2013 | 43 | 0.110 |
Why?
|
| Immunologic Memory | 1 | 2013 | 38 | 0.110 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2013 | 45 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2013 | 83 | 0.110 |
Why?
|
| Vaccines, Synthetic | 3 | 2008 | 72 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 2721 | 0.110 |
Why?
|
| Disease Outbreaks | 2 | 2003 | 155 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 33 | 0.100 |
Why?
|
| Bunyaviridae Infections | 1 | 2011 | 5 | 0.100 |
Why?
|
| Neutralization Tests | 5 | 2012 | 53 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2012 | 753 | 0.100 |
Why?
|
| Seasons | 1 | 2012 | 112 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2003 | 103 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 149 | 0.100 |
Why?
|
| Viremia | 2 | 2008 | 42 | 0.100 |
Why?
|
| Environment | 1 | 2012 | 138 | 0.100 |
Why?
|
| Middle Aged | 7 | 2021 | 10129 | 0.100 |
Why?
|
| Cell Line | 4 | 2019 | 1354 | 0.090 |
Why?
|
| Data Collection | 1 | 2011 | 194 | 0.090 |
Why?
|
| Yellow Fever Vaccine | 1 | 2010 | 1 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1130 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 534 | 0.090 |
Why?
|
| Phylogeny | 4 | 2017 | 644 | 0.090 |
Why?
|
| RNA, Viral | 4 | 2013 | 301 | 0.090 |
Why?
|
| Proteomics | 1 | 2012 | 325 | 0.090 |
Why?
|
| Urban Population | 1 | 2011 | 333 | 0.090 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 24 | 0.080 |
Why?
|
| Weaning | 1 | 2008 | 15 | 0.080 |
Why?
|
| Proteins | 1 | 2012 | 369 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 22 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 54 | 0.080 |
Why?
|
| Logistic Models | 1 | 2011 | 923 | 0.080 |
Why?
|
| Cross Reactions | 3 | 2021 | 83 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 76 | 0.080 |
Why?
|
| Encephalomyelitis, Venezuelan Equine | 1 | 2008 | 1 | 0.080 |
Why?
|
| Sindbis Virus | 1 | 2008 | 14 | 0.080 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Encephalitis, St. Louis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Viral Envelope Proteins | 1 | 2007 | 82 | 0.070 |
Why?
|
| Endemic Diseases | 1 | 2007 | 20 | 0.070 |
Why?
|
| Alphavirus Infections | 1 | 2006 | 4 | 0.070 |
Why?
|
| Alphavirus | 1 | 2006 | 7 | 0.070 |
Why?
|
| Molecular Epidemiology | 2 | 2003 | 50 | 0.070 |
Why?
|
| Vaccines, Subunit | 1 | 2006 | 30 | 0.070 |
Why?
|
| Time Factors | 2 | 2008 | 1742 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2007 | 211 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1180 | 0.070 |
Why?
|
| Vaccination | 1 | 2007 | 288 | 0.070 |
Why?
|
| Interferons | 1 | 2005 | 34 | 0.070 |
Why?
|
| Monkeypox virus | 1 | 2005 | 1 | 0.070 |
Why?
|
| Sciuridae | 1 | 2005 | 5 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 628 | 0.060 |
Why?
|
| Dendritic Cells | 2 | 2016 | 113 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1568 | 0.060 |
Why?
|
| Aging | 1 | 2008 | 664 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 617 | 0.060 |
Why?
|
| Kinetics | 2 | 2019 | 708 | 0.060 |
Why?
|
| Serotyping | 3 | 2012 | 36 | 0.060 |
Why?
|
| Sexual Partners | 2 | 2003 | 314 | 0.050 |
Why?
|
| Trisaccharides | 1 | 2022 | 10 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2012 | 1418 | 0.050 |
Why?
|
| Prevalence | 2 | 2021 | 1455 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 184 | 0.050 |
Why?
|
| Mucins | 1 | 2022 | 35 | 0.050 |
Why?
|
| Spleen | 3 | 2009 | 199 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 5363 | 0.050 |
Why?
|
| Incidence | 3 | 2012 | 922 | 0.050 |
Why?
|
| Military Personnel | 1 | 2003 | 90 | 0.050 |
Why?
|
| Base Sequence | 3 | 2012 | 997 | 0.050 |
Why?
|
| Cytokines | 3 | 2012 | 602 | 0.050 |
Why?
|
| New Mexico | 1 | 2021 | 31 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2021 | 18 | 0.050 |
Why?
|
| Cats | 1 | 2021 | 69 | 0.050 |
Why?
|
| Young Adult | 4 | 2012 | 4268 | 0.050 |
Why?
|
| Dogs | 1 | 2021 | 149 | 0.050 |
Why?
|
| Mammals | 1 | 2021 | 105 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1609 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2019 | 28 | 0.040 |
Why?
|
| Population Density | 2 | 2012 | 23 | 0.040 |
Why?
|
| Child | 3 | 2012 | 3131 | 0.040 |
Why?
|
| HIV Infections | 2 | 2003 | 2303 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 188 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 173 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2019 | 109 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 474 | 0.040 |
Why?
|
| Haplorhini | 1 | 2018 | 22 | 0.040 |
Why?
|
| Africa | 1 | 2018 | 76 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 885 | 0.040 |
Why?
|
| Malaysia | 1 | 2017 | 8 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2012 | 1378 | 0.040 |
Why?
|
| Lymphocytes | 2 | 2009 | 118 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2012 | 1492 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2021 | 454 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2016 | 67 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 583 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 59 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 674 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 410 | 0.030 |
Why?
|
| Rain | 1 | 2014 | 7 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2379 | 0.030 |
Why?
|
| Risk Factors | 3 | 2012 | 3562 | 0.030 |
Why?
|
| DNA Primers | 2 | 2006 | 286 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 1033 | 0.030 |
Why?
|
| HLA-A2 Antigen | 1 | 2013 | 3 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 972 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2013 | 81 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 21 | 0.030 |
Why?
|
| HIV Seroprevalence | 2 | 2003 | 14 | 0.030 |
Why?
|
| Primate Diseases | 1 | 2012 | 4 | 0.030 |
Why?
|
| Demography | 2 | 2004 | 175 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2013 | 117 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 132 | 0.030 |
Why?
|
| Leptospira | 2 | 2003 | 22 | 0.030 |
Why?
|
| Lung | 2 | 2006 | 446 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 57 | 0.030 |
Why?
|
| Primates | 1 | 2012 | 36 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 158 | 0.030 |
Why?
|
| Sporozoites | 1 | 2012 | 6 | 0.030 |
Why?
|
| Venezuela | 1 | 2012 | 8 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 23 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 50 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 106 | 0.030 |
Why?
|
| Trees | 1 | 2012 | 19 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1198 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 88 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 78 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2012 | 64 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2013 | 389 | 0.030 |
Why?
|
| Cities | 1 | 2012 | 63 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 399 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 121 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 103 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 180 | 0.020 |
Why?
|
| Housing | 1 | 2012 | 59 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 217 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 180 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 448 | 0.020 |
Why?
|
| Bolivia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 400 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 387 | 0.020 |
Why?
|
| Fever of Unknown Origin | 1 | 2010 | 7 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2010 | 14 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 182 | 0.020 |
Why?
|
| Absenteeism | 1 | 2010 | 11 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 64 | 0.020 |
Why?
|
| Toxicity Tests | 1 | 2010 | 43 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2009 | 10 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 808 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 6741 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2009 | 32 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 129 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1046 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 61 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 168 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 15 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 20 | 0.020 |
Why?
|
| Brain | 2 | 2006 | 1346 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2007 | 17 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2007 | 79 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2007 | 8 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2007 | 8 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 265 | 0.020 |
Why?
|
| Carrier State | 1 | 2007 | 29 | 0.020 |
Why?
|
| Immunization | 1 | 2007 | 92 | 0.020 |
Why?
|
| Point Mutation | 1 | 2007 | 93 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2006 | 74 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 70 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2005 | 7 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2005 | 14 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 107 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2005 | 43 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 623 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1618 | 0.020 |
Why?
|
| Pupa | 1 | 2004 | 5 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 290 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 893 | 0.020 |
Why?
|
| Urban Health | 1 | 2004 | 95 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2005 | 250 | 0.020 |
Why?
|
| Larva | 1 | 2004 | 124 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2005 | 157 | 0.010 |
Why?
|
| Heart | 1 | 2005 | 180 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2002 | 8 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 225 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 933 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3483 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 479 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2003 | 121 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 455 | 0.010 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2003 | 164 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 730 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2003 | 609 | 0.010 |
Why?
|